Role of oral hypoglycaemic drugs in preventing complication in non-alcoholic fatty liver disease with type 2 diabetes mellitus.
口服降血糖藥物在預防2型糖尿病合併非酒精性脂肪肝疾病併發症中的作用。
J Pak Med Assoc 2024-09-16
Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies.
降糖藥物與2型糖尿病患者肝臟相關結果的關聯:一項系統性回顧的縱向人口基礎研究。
Diabet Med 2024-09-28
Non-alcoholic Fatty Liver Disease (NAFLD) and its association with kidney and cardiovascular outcomes in moderate to advanced chronic kidney disease.
非酒精性脂肪肝病 (NAFLD) 與中度至重度慢性腎病的腎臟及心血管結果之關聯。
Am J Nephrol 2024-10-06
Impact of Sodium-Glucose Co-Transporter Type-2 Inhibitors on Alanine Aminotransferase Levels in Type-2 Diabetes Patients Having Features of Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study in Pakistan.
鈉-葡萄糖共轉運蛋白2型抑制劑對具有非酒精性脂肪肝病特徵的2型糖尿病患者丙氨酸氨基轉移酶水平的影響:巴基斯坦的一項回顧性隊列研究。
Pak J Med Sci 2024-12-05
The Bidirectional Relationship Between Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study.
2型糖尿病與代謝功能障礙相關脂肪肝疾病之間的雙向關係:一項回顧性隊列研究。
Cureus 2025-01-21
Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors.
非酒精性脂肪肝疾病治療新進展:鈉-葡萄糖共轉運蛋白2抑制劑(SGLT2 inhibitors)的角色
Life Sci 2025-04-17
Mortality for Any Hepatic Cause in People With Diabetes Compared to the Non-Diabetic Population. A 10-Year-Observational Study.
糖尿病患者與非糖尿病族群肝臟相關死亡率之比較:一項為期十年的觀察性研究
Liver Int 2025-04-27
Research letter: the global clinical trial landscape for non-alcoholic fatty liver disease (NAFLD) current status and future prospects.
研究短文:非酒精性脂肪肝疾病(NAFLD)全球臨床試驗現況與未來展望
Int J Surg 2025-06-06